Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-21-020407
Filing Date
2021-08-18
Accepted
2021-08-18 16:01:47
Documents
4
Effectiveness Date
2021-08-18
Reference 429
333-239213

Document Format Files

Seq Description Document Type Size
1 FORM S-8 acrx20210817_s8.htm S-8 83117
2 EXHIBIT 5.1 ex_276796.htm EX-5.1 8736
3 EXHIBIT 23.1 ex_276794.htm EX-23.1 2506
4 c01.jpg GRAPHIC 3492
  Complete submission text file 0001437749-21-020407.txt   100327
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258896 | Film No.: 211186676
SIC: 2834 Pharmaceutical Preparations